Oct. 6, 2021
11:30 a.m. CT
Biofluid biomarkers have established value predicting cognitive and functional decline. However, their associations with neuropsychiatric symptoms are widely unknown. Furthermore, neuropsychiatric syndromes may serve as proxy markers for neuropathological change. In this first webinar, we will discuss the current knowledge on biological predictors of neuropsychiatric syndromes and the role of biofluid biomarkers as outcome measures in longitudinal studies.
Corinne Fischer and Rawan Tarawneh